Hodgkin disease: prognostic factors and treatment strategies
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference35 articles.
1. Curability of Advanced Hodgkin's Disease with Chemotherapy
2. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP
3. Clinical stages I and II Hodgkin's disease: a specifically tailored therapy according to prognostic factors.
4. Risk Factor Adapted Treatment of Hodgkin’s Lymphoma: Strategies and Perspectives
5. A Prognostic Score for Advanced Hodgkin's Disease
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Sentinel Amenable Mortality: A New Way to Assess the Quality of Healthcare by Examining Causes of Premature Death for Which Highly Efficacious Medical Interventions Are Available;BioMed Research International;2018-09-02
2. Hematolymphoid Lesions;Surgical Pathology of Liver Tumors;2015
3. Impressive response to pegylated liposomal doxorubicin after allogeneic transplantation in a multi-relapsed Hodgkin's lymphoma;Hematological Oncology;2014-09-22
4. Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients;Journal of Hematology & Oncology;2013-08-29
5. MiR-SNPs as Markers of Toxicity and Clinical Outcome in Hodgkin Lymphoma Patients;PLoS ONE;2013-05-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3